NASDAQ:OYST
Delisted
Oyster Point Pharma Inc Stock Company Profile
$11.17
+0 (+0%)
At Close: Mar 29, 2023
Information
202 Carnegie Center, Suite 109
Princeton NJ 08540
609 382 9032
www.oysterpointrx.com
Industry: Biotechnology
Sector: Healthcare
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.
